Journal
MOLECULES
Volume 27, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/molecules27030658
Keywords
SARS-CoV-2; S antibodies; serine protease inhibitors; 3CLpro inhibitors; RdRp inhibitors; JAK-STAT inhibitors; corticoids; SphK2 inhibitors; IL6 antibodies
Ask authors/readers for more resources
The treatment of COVID-19 requires pharmacological intervention targeting both the viral infection and inflammatory stages. Antiviral drugs can target viral proteins and host proteins, with the latter having the advantage of being effective against all variants of the virus. In addition, drugs targeting the hyperinflammatory phase of the disease, such as JAK kinases inhibitors and anti-inflammatory corticosteroids, are also important strategies.
In spite of advances in vaccination, control of the COVID-19 pandemic will require the use of pharmacological treatments against SARS-CoV2. Their development needs to consider the existence of two phases in the disease, namely the viral infection and the inflammatory stages. The main targets for antiviral therapeutic intervention are: (a) viral proteins, including the spike (S) protein characteristic of the viral cover and the viral proteases in charge of processing the polyprotein arising from viral genome translation; (b) host proteins, such as those involved in the processes related to viral entry into the host cell and the release of the viral genome inside the cell, the elongation factor eEF1A and importins. The use of antivirals targeted at host proteins is less developed but it has the potential advantage of not being affected by mutations in the genome of the virus and therefore being active against all its variants. Regarding drugs that address the hyperinflammatory phase of the disease triggered by the so-called cytokine storm, the following strategies are particularly relevant: (a) drugs targeting JAK kinases; (b) sphingosine kinase 2 inhibitors; (c) antibodies against interleukin 6 or its receptor; (d) use of the traditional anti-inflammatory corticosteroids.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available